Corient Capital Partners’s Eli Lilly LLY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q3	$14M	Hold	43,239	–	–	1.05%	13
2022 Q2	$14M	Sell	43,239 -1,806	-4%	-$586K	1.06%	13
2022 Q1	$12.9M	Buy	45,045 +2,082	+5%	+$596K	0.85%	17
2021 Q4	$11.9M	Sell	42,963 -173	-0.4%	-$47.8K	0.79%	20
2021 Q3	$9.97M	Buy	43,136 +2,514	+6%	+$581K	0.73%	22
2021 Q2	$9.32M	Buy	40,622 +2,795	+7%	+$642K	0.68%	26
2021 Q1	$7.07M	Sell	37,827 -5,252	-12%	-$981K	0.61%	37
2020 Q4	$7.27M	Sell	43,079 -534	-1%	-$90.2K	0.73%	30
2020 Q3	$6.46M	Sell	43,613 -2,199	-5%	-$326K	0.74%	28
2020 Q2	$7.52M	Buy	45,812 +5,394	+13%	+$886K	0.92%	16
2020 Q1	$5.61M	Buy	40,418 +8,853	+28%	+$1.23M	0.88%	24
2019 Q4	$4.15M	Buy	31,565 +2,520	+9%	+$331K	0.53%	42
2019 Q3	$3.25M	Buy	29,045 +2,622	+10%	+$293K	0.46%	50
2019 Q2	$2.93M	Sell	26,423 -2,928	-10%	-$324K	0.45%	49
2019 Q1	$3.81M	Buy	29,351 +2,069	+8%	+$269K	0.62%	31
2018 Q4	$3.16M	Sell	27,282 -10,002	-27%	-$1.16M	0.56%	37
2018 Q3	$4M	Hold	37,284	–	–	0.67%	28
2018 Q2	$3.18M	Sell	37,284 -18,330	-33%	-$1.56M	0.56%	36
2018 Q1	$4.3M	Sell	55,614 -10,958	-16%	-$848K	0.79%	27
2017 Q4	$5.62M	Buy	66,572 +2,646	+4%	+$223K	0.96%	17
2017 Q3	$5.47M	Sell	63,926 -18,900	-23%	-$1.62M	1.03%	15
2017 Q2	$6.82M	Sell	82,826 -1,394	-2%	-$115K	1.04%	17
2017 Q1	$7.08M	Buy	84,220 +49,437	+142%	+$4.16M	1.1%	12
2016 Q4	$2.56M	Sell	34,783 -42,634	-55%	-$3.14M	0.45%	53
2016 Q3	$6.21M	Buy	+77,417	New	+$6.21M	1.15%	10